Ingevity reported record sales of $482.0 million, up 27.9% year-over-year, driven by strong demand and increased prices. Net income was $75.4 million, with diluted EPS of $1.98. Adjusted EBITDA reached a record $138.2 million, up 15.6% year-over-year, with an adjusted EBITDA margin of 28.7%. The company raised its full-year 2022 sales and adjusted EBITDA guidance.
Company delivered record sales of $482.0 million, up 27.9%.
Net income of $75.4 million and diluted earnings per share (EPS) of $1.98; adjusted earnings of $79.4 million and record diluted adjusted EPS of $2.09.
Record adjusted EBITDA of $138.2 million, up 15.6% and adjusted EBITDA margin of 28.7%.
Company raises full year 2022 sales guidance to between $1.65 billion and $1.70 billion and adjusted EBITDA to between $460 million and $475 million.
The company raised its 2022 guidance to sales between $1.65 billion and $1.70 billion, and adjusted EBITDA between $460 million and $475 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance